Speed Reads
Johnson & Johnson on Thursday applied for emergency use authorization from the Food and Drug Administration for its COVID-19 vaccine.
This is a single-dose vaccine that can be stored in a refrigerator. If approved, it will be the third coronavirus vaccine authorized for emergency use in the U.S., after the Pfizer/BioNTech and Moderna products.
Last week, Johnson & Johnson said its vaccine is 66 percent effective against moderate to severe infections, while offering protection against hospitalization and death. It is less effective against the COVID-19 variant first discovered in South Africa.
The FDA will now review the company's submission, and an authorization could come sometime in the next few weeks, Politico reports.